Transformation of ENABLE into FEBS-IUBMB-ENABLE guarantees the continuity of the initiative for the next four years
- The ENABLE conferences have so far been organised entirely by PhD students and postdoctoral researchers from IRB Barcelona, RIMLS, CPR and SEMM.
- Funding from FEBS and IUBMB ensures the continuity of ENABLE, allowing the incorporation of a co-organising institution and spreading the lessons learned from ENABLE.
- The 2022, 2023 and 2025 conferences will take place in Europe while the 2024 event will be the first to be held outside Europe.
Initially funded by the European Commission’s Horizon 2020 programme, the first four ENABLE conferences were held in the cities hosting the headquarters of the four entities leading the project: the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain; the Radboud Institute for Molecular Life Sciences (RIMLS) in Nijmegen, The Netherlands; The Novo Nordisk Foundation Center for Protein Research (CPR) in Copenhagen, Denmark; and the Scuola Europea di Medicina Molecolare (SEMM), in Milan, Italy.
In this new cycle of conferences, FEBS, IUBMB and the four core ENABLE institutions have joined forces to share ENABLE best practices with other international research institutions. To this end, in addition to the four core research centres, other institutions can apply to become associated centres and host one of the events. For the 2024 event, FEBS-IUBMB-ENABLE will actively search for an associated centre in a non-European country to ensure that one of the events is held on another continent.